Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 19, 2026Aug 20 8:30 PMSoleil BoughtonChief Legal Officer
Sale
25,111$27.55$691.8K313,964(D)

View →

Aug 19, 2026Aug 19 1:41 PMBoughton Soleil
Proposed Sale
25,111$27.55$691.8K—

View →

Aug 17, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Sale
9,388$27.89$261.8K264,117(D)

View →

Jun 18, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Sale
55,383$35.09$1.9M228,938(D)

View →

Aug 18, 2026Aug 18 2:37 PMAutor Deborah M.
Proposed Sale
16,773$27.85$467.1K—

View →

Jul 22, 2026Jul 22 3:12 PMPendarvis Christiane
Proposed Sale
3,500$32.37$113.3K—

View →

Jul 17, 2026Jul 20 8:30 PMOluyemi OkupeChief Financial Officer
Sale
7,163$31.99$229.2K284,321(D)

View →

Jul 6, 2026Jul 7 8:20 PMOluyemi OkupeChief Financial Officer
Sale
7,163$36.49$261.4K284,321(D)

View →

Jul 6, 2026Jul 6 10:17 PMOluyemi Okupe
Proposed Sale
28,652$38.28$1.1M—

View →

Jun 18, 2026Jun 23 10:39 PMPatrick Harrison CarrollChief Medical Officer
Sale
23,726$35.00$830.4K181,861(D)

View →

Jun 22, 2026Jun 23 10:39 PMOluyemi OkupeChief Financial Officer
Sale
18,197$34.03$619.2K284,321(D)

View →

Jun 18, 2026Jun 18 7:02 PMCarroll Patrick Harrison
Proposed Sale
23,726$35.00$830.4K—

View →

Jun 17, 2026Jun 17 10:50 PMMichael ChiChief Operating Officer
Sale
14,027$31.50$441.9K432,124(D)

View →

Jun 17, 2026Jun 17 10:50 PMIrene BecklundPAO
Sale
4,490$31.50$141.4K6,790(D)

View →

Jun 16, 2026Jun 17 10:50 PMIrene BecklundPAO
Sale
7,573$30.25$229.1K11,280(D)

View →

Jun 17, 2026Jun 17 10:50 PMMohamed ElshenawyCTO
Sale
30,040$31.50$946.3K101,023(D)

View →

Jun 17, 2026Jun 17 3:17 PMBecklund Irene
Proposed Sale
4,490$31.50$141.4K—

View →

Jun 17, 2026Jun 17 3:10 PMElshenawy Mohamed
Proposed Sale
30,040$31.50$946.3K—

View →

Jun 17, 2026Jun 17 1:47 PMChi Michael
Proposed Sale
14,027$31.50$441.9K—

View →

Jun 16, 2026Jun 16 3:21 PMBecklund Irene
Proposed Sale
7,573$30.25$229.1K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4